ストックスクリーナーアプリを入手
436.79
0.95%
-4.21
アフターアワーズ：
434.99
-1.80
-0.41%
前日終値:
$441.00
開ける：
$441.33
24時間の取引高:
1.81M
Relative Volume:
0.89
時価総額：
$164.88B
収益：
$42.88B
当期純損益:
$6.34B
株価収益率:
26.42
EPS:
16.53
ネットキャッシュフロー:
$7.27B
1週間 パフォーマンス:
-3.70%
1か月 パフォーマンス:
-16.33%
6か月 パフォーマンス:
-26.16%
1年 パフォーマンス:
-21.24%
1日の値動き範囲:
$435.36
$445.94
1週間の範囲:
$415.31
$450.84
52週間の値動き範囲:
$409.85
$627.88
Thermo Fisher Scientific Inc Stock (TMO) Company Profile
名前
Thermo Fisher Scientific Inc
セクター
電話
(781) 622-1000
住所
168 THIRD AVENUE, WALTHAM, MA
TMO を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
TMO
Thermo Fisher Scientific Inc
|
436.79 | 164.88B | 42.88B | 6.34B | 7.27B | 16.53 |
|
DHR
Danaher Corp
|
190.66 | 136.41B | 23.88B | 3.90B | 5.30B | 5.28 |
|
IDXX
Idexx Laboratories Inc
|
402.38 | 32.61B | 3.90B | 887.87M | 798.08M | 10.67 |
|
A
Agilent Technologies Inc
|
102.70 | 29.28B | 6.53B | 1.26B | 1.31B | 4.35 |
|
IQV
Iqvia Holdings Inc
|
148.44 | 26.17B | 15.41B | 1.37B | 2.11B | 7.50 |
Thermo Fisher Scientific Inc Stock (TMO) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-01-10 | アップグレード | Bernstein | Mkt Perform → Outperform |
| 2024-12-23 | 開始されました | Scotiabank | Sector Perform |
| 2024-10-14 | 開始されました | Redburn Atlantic | Buy |
| 2024-10-01 | 開始されました | Stephens | Overweight |
| 2024-08-28 | 開始されました | Wells Fargo | Overweight |
| 2024-06-03 | 再開されました | Jefferies | Buy |
| 2024-03-18 | 再開されました | Citigroup | Neutral |
| 2024-01-24 | ダウングレード | Barclays | Overweight → Equal Weight |
| 2024-01-08 | ダウングレード | Bernstein | Outperform → Mkt Perform |
| 2023-12-18 | 開始されました | HSBC Securities | Buy |
| 2023-12-13 | 開始されました | Wolfe Research | Outperform |
| 2023-10-26 | ダウングレード | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2023-10-25 | アップグレード | Wells Fargo | Underweight → Equal Weight |
| 2023-09-28 | 開始されました | Bernstein | Outperform |
| 2023-09-06 | 再開されました | Citigroup | Buy |
| 2023-07-19 | 開始されました | Raymond James | Outperform |
| 2023-07-19 | 繰り返されました | Robert W. Baird | Outperform |
| 2023-07-13 | アップグレード | Credit Suisse | Neutral → Outperform |
| 2023-04-04 | 繰り返されました | Barclays | Overweight |
| 2022-12-14 | 開始されました | Deutsche Bank | Buy |
| 2022-12-07 | 開始されました | RBC Capital Mkts | Outperform |
| 2022-10-27 | ダウングレード | The Benchmark Company | Buy → Hold |
| 2022-08-25 | 開始されました | Credit Suisse | Neutral |
| 2022-04-25 | ダウングレード | Wells Fargo | Equal Weight → Underweight |
| 2022-01-26 | 再開されました | Barclays | Overweight |
| 2021-10-20 | アップグレード | Citigroup | Neutral → Buy |
| 2021-10-15 | 再開されました | Cowen | Outperform |
| 2021-08-05 | 再開されました | Credit Suisse | Outperform |
| 2021-07-16 | 開始されました | The Benchmark Company | Buy |
| 2021-03-18 | アップグレード | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2021-03-03 | 開始されました | Barclays | Overweight |
| 2021-01-08 | アップグレード | Credit Suisse | Neutral → Outperform |
| 2020-12-16 | ダウングレード | Citigroup | Buy → Neutral |
| 2020-12-02 | 開始されました | Goldman | Buy |
| 2020-11-10 | 開始されました | KeyBanc Capital Markets | Sector Weight |
| 2020-09-30 | 開始されました | Atlantic Equities | Overweight |
| 2020-09-14 | 開始されました | Morgan Stanley | Overweight |
| 2020-08-20 | 再開されました | JP Morgan | Overweight |
| 2020-07-15 | アップグレード | Cleveland Research | Neutral → Buy |
| 2020-07-07 | 繰り返されました | Needham | Buy |
| 2020-04-23 | 繰り返されました | Needham | Buy |
| 2020-01-31 | 繰り返されました | Needham | Buy |
| 2020-01-22 | 開始されました | Credit Suisse | Neutral |
| 2020-01-08 | 開始されました | Wells Fargo | Equal Weight |
| 2020-01-07 | 開始されました | Citigroup | Buy |
| 2019-11-15 | 開始されました | Stifel | Buy |
| 2019-07-25 | 繰り返されました | Needham | Buy |
| 2019-07-16 | ダウングレード | Needham | Strong Buy → Buy |
| 2019-05-30 | 開始されました | Wolfe Research | Outperform |
| 2019-05-23 | 繰り返されました | Needham | Strong Buy |
| 2019-04-22 | 繰り返されました | Needham | Strong Buy |
| 2019-04-16 | 繰り返されました | BofA/Merrill | Buy |
すべてを表示
Thermo Fisher Scientific Inc (TMO) 最新ニュース
Thermo Fisher Scientific named founding sponsor of LifeSciNKY - LINK nky
Global In-Vitro Diagnostics Market Predicted to Surpass the USD 90 Billion Mark by 2032 | DelveInsight - GlobeNewswire Inc.
Bernstein Cuts Price Target on Thermo Fisher Scientific to $585 From $690, Keeps Outperform Rating - MarketScreener
Baird Cuts Price Target on Thermo Fisher Scientific to $603 From $660, Keeps Outperform Rating - MarketScreener
Analysts Estimate Thermo Fisher Scientific (TMO) to Report a Decline in Earnings: What to Look Out for - Yahoo Finance
Next Generation Sequencing Market on the Rise: Applications & - openPR.com
Thermo Fisher stock gains after Sartorius Q1 results (TMO) - Seeking Alpha
Robust Specialty Diagnostics Segment Likely to Aid TMO's Q1 Earnings - TradingView
Northern Kentucky-based LifeSciKY announces Thermo Fisher Scientific as founding sponsor - Northern Kentucky Tribune
Thermo Fisher Scientific - WACH
LifeSciKY inks partnership with Thermo Fisher Scientific as Founding Sponsor - Yahoo Finance
Thermo Fisher acquires Solventum’s PF business in $4.1bn deal - Financier Worldwide
Thermo Fisher Scientific Stock Up 1.3% After Key Signal - Benzinga
Sickle Cell Anemia Testing and Screening Market Detailed In New - openPR.com
Thermo Fisher Scientific launches bench scale bioreactor enabling productivity, scalability and efficiency - BioSpectrum Asia
3d Cell Culture Market Set to Witness Significant Growth - openPR.com
Thermo Fisher Scientific Introduces the 5L DynaDrive Single-Use Bioreactor to Simplify and Accelerate Process Development and Help Bring Therapies to Market Faster - The Tribune
Thermo Fisher Scientific (NYSE:TMO) Launches 5L DynaDrive Bioreactor To Enhance Bioprocessing - simplywall.st
Thermo Fisher Scientific And Its Real Value (NYSE:TMO) - Seeking Alpha
BofA Securities Cuts Price Target on Thermo Fisher Scientific to $545 From $680, Keeps Buy Rating - MarketScreener
Helicobacter Pylori Diagnostics Market Is Booming Worldwide | Thermo Fisher Scientific, Inc., Bio-Rad Laboratories Inc. - openPR.com
Thermo Fisher Scientific Introduces 5L DynaDrive Single-Use Bioreactor - Contract Pharma
SPONSORED Boys & Girls Clubs and Thermo Fisher Scientific fuel the future of STEM - Axios
Why Thermo Fisher Scientific (TMO) Is One of the Best Medical Stocks to Buy According to Billionaires - Insider Monkey
Bernstein maintains Thermo Fisher stock with $690 target - Investing.com
Ultrasonic Aspirator Market Poised for Rapid Growth, Expected - openPR.com
Nucleic Acid Isolation And Purification Market Generated - openPR.com
Thermo Fisher Scientific Inc (TMO) Trading Down 6.22% on Apr 10 - GuruFocus
Meningitis Diagnostic Testing Market Deep Research Report with - openPR.com
The Zacks Analyst Blog Highlights Eli Lilly, American Express, Thermo Fisher, Steel Partners and Oil-Dri - Yahoo Finance
Escherichia Coli Strain Market to Witness Remarkable Growth - openPR.com
Nanorobotics Market Set to Witness Significant Growth - openPR.com
Top Research Reports for Eli Lilly, American Express & Thermo Fisher - Yahoo Finance
Barclays Adjusts Price Target on Thermo Fisher Scientific to $475 From $620 - MarketScreener
Assisted Reproductive Technology Market Forecast Report and Company Analysis 2025-2033 Featuring Thermo Fisher Scientific, Sumitomo Mitsui, CooperSurgical, Fujifilm, Merck, Progyny, Cosmos BiomedicalResearchAndMarkets.com - Bluefield Daily Telegraph
gRNA Market Top Companies StudyThermo Fisher Scientific Inc., - openPR.com
Thermo Fisher (TMO) Surges 8.2%: Is This an Indication of Further Gains? - Nasdaq
Electrocompetent Cells Market Poised to Achieve Robust Growth - openPR.com
Thermo Fisher Scientific, NSG BIO Collaborate to Strengthen Singapore's Biotech Startup Ecosystem - digitimes
Genotyping Assay Market Surges to USD 37.1 Billion by 2029: - openPR.com
Thermo Fisher Scientific Inc. (TMO): Among the High Growth Dividend Paying Stocks to Invest in - Insider Monkey
Earnings Preview: What to Expect From Thermo Fisher Scientific's Report - Nasdaq
Thermo Fisher stock price target cut to $600 at TD Cowen - Investing.com India
Thermo Fisher Scientific releases Krios 5 Cryo-TEM microscope - Scientist Live
Wolfe Research Adjusts PT on Thermo Fisher Scientific to $535 From $665, Maintains Outperform Rating - MarketScreener
Earnings Preview: What To Expect From Thermo Fisher Scientific's Report - Barchart.com
Thermo Fisher Scientific, NSG BIO collaborate to strengthen Singapore's biotech startup ecosystem - BioSpectrum Asia
Genomics Market Deep Research Report with Forecast to 2032 | Thermo Fisher Scientific, Inc., Agilent Technologies - openPR.com
New Krios 5 Cryo-TEM from Thermo Fisher delivers up to 25% throughput gain for atomic-resolution analysis - R&D World
Thermo Fisher Scientific launches the Krios 5 Cryo-Transmission Electron Microscope - SelectScience
RBC Cuts Price Target on Thermo Fisher Scientific to $651 From $694, Keeps Outperform Rating - MarketScreener
Thermo Fisher Scientific Inc (TMO) 財務データ
収益
当期純利益
現金流量
EPS
0.39%
0.41%
大文字化:
|
ボリューム (24 時間):